Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2016010518091N7Phase 3Completed
Phase 3, randomised trial of midazolam and ketamine (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoint: Delirium after awakening from anesthesia. Started Jan 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2016010518091N7.